Short -acting β2agonist (SABA)
Showing 1 - 25 of >10,000
Healthy Trial in Edmonton (Salbutamol 400mcg, Budesonide/formoterol, Placebo)
Recruiting
- Healthy
- Salbutamol 400mcg
- +2 more
-
Edmonton, Alberta, CanadaClinical Physiology Laboratory
Sep 5, 2023
Bronchial Asthma Trial in Chandigarh (Single Inhalation technique, Tidal inhalation technique)
Recruiting
- Bronchial Asthma
- Single Inhalation technique
- Tidal inhalation technique
-
Chandigarh, India
- +1 more
Jun 23, 2022
Tiotropium and Olodaterol in Comparison to Triple Therapy
Completed
- Pulmonary Disease, Chronic Obstructive
- Tiotropium and Olodaterol (Tio+Olo)
- Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS)
-
Andover, MassachusettsHealthCore, Inc.
Nov 12, 2021
SABINA INTERNATIONAL
Completed
- Asthma
-
San Salvador, ArgentinaResearch Site
Feb 9, 2021
Asthma Trial (BDA MDI, AS MDI)
Not yet recruiting
- Asthma
- BDA MDI
- AS MDI
- (no location specified)
Aug 15, 2022
Asthma Trial (MF/F Metered Dose Inhaler (MDI) 25/5 mcg, MF/F MDI 50/5 mcg, MF/F MDI 100/5 mcg)
Withdrawn
- Asthma
- MF/F Metered Dose Inhaler (MDI) 25/5 mcg
- +6 more
- (no location specified)
Feb 7, 2022
COPD Trial in Chongqing (Glucocorticoids, Antibiotics, Inhaled corticosteroid (ICS))
Completed
- Chronic Obstructive Pulmonary Disease
- Glucocorticoids
- +6 more
-
Chongqing, Chongqing, ChinaDaping Hospital
Oct 22, 2020
Airway Inflammation, Asthma Trial in United Kingdom (SYMBICORT and salbutamol)
Active, not recruiting
- Airway Inflammation
- Asthma
- SYMBICORT and salbutamol
-
Bradford, United Kingdom
- +5 more
Aug 22, 2022
Reversibility of Bronchial Obstruction in Children Born Preterm
Recruiting
- Bronchopulmonary Dysplasia
- +6 more
-
Prague, CzechiaFirst faculty of Medicine, Charles university.
Oct 29, 2023
Copd Trial in Assiut (SABA SAMA ICS Vs LABA LAMA ICs)
Not yet recruiting
- Copd
- SABA SAMA ICS Vs LABA LAMA ICs
-
Assiut, EgyptNermen Mohammed Abuelkassem
Feb 28, 2023
Copd Trial in Dallas (TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation)
Not yet recruiting
- Copd
- TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation
-
Dallas, TexasBaylor Scott & White Health Research Institute
Mar 22, 2022
COPD Trial in Worldwide (Itepekimab (SAR440340), Placebo, Any Inhaled Corticosteroids as prescribed by treating physician as
Completed
- Chronic Obstructive Pulmonary Disease
- SAR440340
- +5 more
-
Los Angeles, California
- +82 more
Oct 28, 2022
Asthma Trial in United States (Fluticasone propionate/salmeterol (FS), Albuterol, Standard of Care Asthma Medication)
Completed
- Asthma
- Fluticasone propionate/salmeterol (FS)
- +3 more
-
Phoenix, Arizona
- +45 more
Jul 15, 2022
Bronchiolitis Trial in Guadarrama (Assisted autogenous drainage group (DAA), Group prolonged slow expiration (ELPr), Control
Completed
- Bronchiolitis
- Assisted autogenous drainage group (DAA)
- +2 more
-
Guadarrama, Madrid, SpainJ.Nicolas Cuenca Zaldivar
Apr 6, 2022
COPD Greek Patients Based on Standard Clinical Practice.
Not yet recruiting
- Copd
- COPD Exacerbation
- (no location specified)
Jun 22, 2022
Phenotyping Disease Severity in Asthma
Recruiting
- Asthma
- Bronchoscopy
-
Calgary, Alberta, CanadaUniversity of Calgary
May 18, 2022
Hypertrophy, Physiologic Hypertrophy, Physical Activity Trial in Copenhagen (Formoterol, Terbutaline, Placebo)
Unknown status
- Hypertrophy
- +2 more
- Formoterol
- +2 more
-
Copenhagen, DenmarkAugust Krogh Building
Mar 24, 2020
Puerto Rican Children With Asthma
Completed
- Asthma in Children
- Inhaled corticosteroid (mometasone)
-
Pittsburgh, Pennsylvania
- +1 more
Jul 6, 2022